Publikationen 2009

  • Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage.Linker RA, Brechlin P, Jesse S, Steinacker P, Lee DH, Asif AR, Jahn O, Tumani H, Gold R, Otto M. PLoS One. 2009 Oct 28;4(10):e7624.

 

  • Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Stegbauer J, Lee DH, Seubert S, Ellrichmann G, Manzel A, Kvakan H, Muller DN, Gaupp S, Rump LC, Gold R, Linker RA. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14942-7.

 

  • Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. Linker R, Gold R, Luhder F. Crit Rev Immunol. 2009;29(1):43-68. Review.

 

  • Immunomodulation and postpartum relapses in patients with multiple sclerosis. Hellwig K, Beste C, Schimrigk S, Chan A (2009)

 

  • Therapeutic Advances in Neurological Disorders, 2: 7-11.

 

  • Severe cardiac failure in a multiple sclerosis patient following low dose mitoxantrone treatment. Dörr J, Bitsch A, Schmailzl KJG, Chan A, von Ahsen N, Hummel M, Varon R, Lill CM, Vogel HP, Zipp F, Paul F (2009). Neurology, 73: 991-993.    

 

  • Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis. Bayas A, Stasiolek M, Kruse N, Toyka KV, Selmaj K, Gold R. Clin Exp Immunol. 2009 Sep;157(3):332-42.

 

  • ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Cotte S, von Ahsen N, Kruse N, Huber B, Winkelmann A, Zettl UK, Starck M, König N, Tellez N, Dörr J, Paul F, Zipp F, Lühder F, Koepsell H, Pannek H, Montalban X, Gold R, Chan A. Brain. 2009 Sep;132(Pt 9):2517-30.

 

  • Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener¹s Granulomatosis and confirmation for multiple sclerosis in German patients. Wieczorek S, Hoffjan S, Chan A, Rey L, Harper L, Fricke H, Gross WL, Epplen JT, Lamprecht P. Genes and Immunity, 2009;10: 591-595.

 

  • Small but powerful: short peptide hormones and their role in autoimmune inflammation. Lühder F, Lee DH, Gold R, Stegbauer J, Linker RA. J Neuroimmunol. 2009 Dec 10;217(1-2):1-7. Epub 2009 Sep 12. Review.

 

  • Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system. Haghikia A, Gold R. J Neuroimmunol. 2010 Jan 25;218(1-2):1-2.

 

  • Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R. N Engl J Med. 2009 Sep 10;361(11):1075-80.